Use of MGIT 960 for rapid quantitative measurement of the susceptibility of Mycobacterium tuberculosis complex to ciprofloxacin and ethionamide

Journal of Antimicrobial Chemotherapy

Volumn 53, Issue 4, 2004, Pages 600-603

  Huang, Tsi Shu ^a,b   Lee, Susan Shin Jung ^a   Tu, Hui Zin ^a   Huang, Wen Kuei ^a   Chen, Yao Shen ^a,c   Huang, Chung Kai ^a   Wann, Shue Ren ^a   Lin, Hsi Hsun ^a   Liu, Yung Ching ^a,d  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b FOOYIN UNIVERSITY   (Taiwan)

^c NATIONAL KAOHSIUNG NORMAL UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

M. tuberculosis; Minimum inhibitory concentration; Susceptibility testing

Indexed keywords

AGAR; CIPROFLOXACIN; ETHIONAMIDE; OXYGEN; RADIOISOTOPE; TUBERCULOSTATIC AGENT;

ANALYTIC METHOD; ANALYTICAL EQUIPMENT; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOMATION; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIOSENSOR; CONTROLLED STUDY; EQUIPMENT DESIGN; FLUORESCENCE ANALYSIS; HUMAN; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; QUANTITATIVE ANALYSIS; SAFETY; STANDARDIZATION; VALIDATION PROCESS;

ANTITUBERCULAR AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, MICROBIAL; ETHIONAMIDE; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 16544390121     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh120     Document Type: Article

References (20)

1. Barnes, P. F., Bloch, A. B., Davidson, P. T. et al. (1991). Tuberculosis in patients with human immunodeficiency virus infection. New England Journal of Medicine 324, 1644-50.
2. Chaisson, R. E. & Slutkin, G. (1989). Tuberculosis and human immunodeficiency virus infection. Journal of Infectious Diseases 159, 96-100.
3. Allen, B. W., Mitchison, D. A., Chan, Y. C. et al. (1983). Amikacin in the treatment of pulmonary tuberculosis. Tubercle 64, 111-8.
4. Heifets, L. (2000). Conventional methods for antimicrobial susceptibility testing of Mycobacterium tuberculosis. In Multidrug-resistant Tuberculosis (Bastian, I. & Portaels, F., Eds), pp. 133-43. Kluwer Academic Publications, Dordrecht, The Netherlands.
5. Kent, P. T. & Kubica, G. P. (1985). Public Health Mycobacteriology. A Guide for the Level III Laboratory. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA, USA.
6. Reisner, B. A., Gatson, M. A. & Wood, G. L. (1995). Evaluation of Mycobacteria Growth Indicator Tubes for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin. Diagnostic Microbiology and Infectious Disease 22, 325-9.
7. Inderlied, C. B. (1994). Antimycobacterial susceptibility testing: present practices and future trends. European Journal of Clinical Microbiology and Infectious Diseases 13, 980-93.
8. Inderlied, C. B. & Salfinger, M. (1995). Antimicrobial agents and susceptibility tests: mycobacteria. In Manual of Clinical Microbiology, 6th edn (Murray, P. R., Baron, E. J., Pfaller, M. A. et al., Eds), pp. 1385-404. American Society for Microbiology, Washington, DC, USA.
9. Franzblau, S. G., Witzig, R. S., McLaughlin, J. C. et al. (1998). Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. Journal of Clinical Microbiology 36, 362-6.
10. Palomino, J. C., Traore, H., Fissette, K. et al. (1999). Evaluation of Mycobacteria Growth Indicator Tube (MGIT) for drug susceptibility testing of Mycobacterium tuberculosis. International Journal of Tuberculosis and Lung Disease 3, 344-8.
11. Yajko, D. M., Madej, J. J., Lancaster, M. V. et al. (1995). Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis. Journal of Clinical Microbiology 33, 2324-7.
12. Bemer, P. F., Palicova, S., Rusch-Gerdes, H. et al. (2002). Multicenter evaluation of fully automated BACTEC mycobacteria growth indicator tube 960 for susceptibility testing of Mycobacterium tuberculosis. Journal of Clinical Microbiology 40, 150-4.
13. Goloubeva, V. M., Lecocq, P., Lassowsky, F. et al. (2001). Evaluation of mycobacteria growth indicator tube for direct and indirect drug susceptibility testing of Mycobacterium tuberculosis from respiratory specimens in a Siberian prison hospital. Journal of Clinical Microbiology 39, 1501-5.
14. Huang, T. S., Tu, H. Z., Lee, S. S. J. et al. (2002). Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs: comparisons of the MGIT 960 and BACTEC 460 systems. Annals of Clinical and Laboratory Science 32, 142-7.
15. Pfyffer, G. E., Bonato, D. A., Ebrahimzadeh, A. et al. (1999). Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs using the radiometric BACTEC 460 technique and the proportion method with solid media. Journal of Clinical Microbiology 37, 3179-86.
16. Rüsch-Gerdes, S., Domehl, C., Nardi, G. et al. (1999). Multicenter evaluation of the mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs. Journal of Clinical Microbiology 37, 45-8.
17. Walters, S. B. & Hanna, B. A. (1996). Testing of susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by mycobacterium growth indicator tube method. Journal of Clinical Microbiology 34, 1565-7.
18. Pfyffer, G. E., Palicova, F. & Rusch-Gerdes, S. (2002). Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide with the nonradiometric BACTEC MGIT 960 system. Journal of Clinical Microbiology 40, 1670-4.
19. Bastian, I., Rigouts, L., Palomino, J. C. et al. (2001). Kanamycin susceptibility testing of Mycobacterium tuberculosis using Mycobacterium Growth Indicator Tube and a colorimetric method. Antimicrobial Agents and Chemotherapy 45, 1934-6.
20. Heifets, L. B. (1991). Drug susceptibility tests in the management of chemotherapy of tuberculosis. In Drug Susceptibility in the Chemotherapy of Mycobacterial Infections, pp. 97. CRC Press, Boca Raton, FL, USA.